These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


324 related items for PubMed ID: 28666961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals.
    Pawłowska I, Pawłowski L, Krzyżaniak N, Kocić I.
    BioDrugs; 2019 Apr; 33(2):183-191. PubMed ID: 30830647
    [Abstract] [Full Text] [Related]

  • 3. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.
    Barbier L, Vandenplas Y, Simoens S, Declerck P, Vulto AG, Huys I.
    J Pharm Policy Pract; 2021 Jun 22; 14(1):53. PubMed ID: 34158128
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Physician and pharmacist perceptions of generic medicines: what they think and how they differ.
    Dunne S, Shannon B, Hannigan A, Dunne C, Cullen W.
    Health Policy; 2014 Jun 22; 116(2-3):214-23. PubMed ID: 24709114
    [Abstract] [Full Text] [Related]

  • 6. Medical specialists' attitudes to prescribing biosimilars.
    Hemmington A, Dalbeth N, Jarrett P, Fraser AG, Broom R, Browett P, Petrie KJ.
    Pharmacoepidemiol Drug Saf; 2017 May 22; 26(5):570-577. PubMed ID: 28233367
    [Abstract] [Full Text] [Related]

  • 7. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians.
    Cohen H, Beydoun D, Chien D, Lessor T, McCabe D, Muenzberg M, Popovian R, Uy J.
    Adv Ther; 2017 Jan 22; 33(12):2160-2172. PubMed ID: 27798772
    [Abstract] [Full Text] [Related]

  • 8. Knowledge, behaviors and practices of community and hospital pharmacists towards biosimilar medicines: Results of a French web-based survey.
    Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M.
    MAbs; 2017 Jan 22; 9(2):383-390. PubMed ID: 27929743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey.
    Chapman SR, Fitzpatrick RW, Aladul MI.
    BMJ Open; 2017 Jun 21; 7(6):e016730. PubMed ID: 28637743
    [Abstract] [Full Text] [Related]

  • 11. Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study.
    Rupert DJ, Jordan AM, Ziemian MA, Brown RM, Fleming NS, Lefebvre RC.
    BioDrugs; 2022 Sep 21; 36(5):645-655. PubMed ID: 35962911
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Knowledge and perceptions of biosimilar medicines by health professionals in Tunisia].
    Mhiri A, Khemakhem M, Kalboussi N, Kacem B.
    Ann Pharm Fr; 2022 May 21; 80(3):327-339. PubMed ID: 34428456
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States.
    Teeple A, Ellis LA, Huff L, Reynolds C, Ginsburg S, Howard L, Walls D, Curtis JR.
    Curr Med Res Opin; 2019 Apr 21; 35(4):611-617. PubMed ID: 30712393
    [Abstract] [Full Text] [Related]

  • 19. European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice.
    Barbier L, Simoens S, Vulto AG, Huys I.
    BioDrugs; 2020 Dec 21; 34(6):797-808. PubMed ID: 33063267
    [Abstract] [Full Text] [Related]

  • 20. Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars.
    Demirkan FG, Sönmez HE, Lamot L, Akgün Ö, Sözeri B, Ayaz NA, PeRA-Research Group.
    BioDrugs; 2022 May 21; 36(3):421-430. PubMed ID: 35380389
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.